BPMC - Blueprint Medicines Corp

QQQ $ 633.20 nm (nm)

DIA $ 475.83 $ -1.36 (-0.29 %)

SPY $ 684.43 nm (nm)

TLT $ 90.42 nm (nm)

GLD $ 371.67 $ 7.13 (1.96 %)

Previous Close

$ 129.46

Open

$ 129.35

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

-- - --

52 Week Range

$ 73.04 - $ 129.65

Volume

2,980,995

Average Volume

Market Cap

8.36B

Beta (5Y Monthly)

$ 1.27

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-01-2025	03-31-2025	10-Q
2	02-13-2025	12-31-2024	10-K
3	10-30-2024	09-30-2024	10-Q
4	08-01-2024	06-30-2024	10-Q
5	05-02-2024	03-31-2024	10-Q
6	02-15-2024	12-31-2023	10-K
7	10-26-2023	09-30-2023	10-Q
8	08-02-2023	06-30-2023	10-Q
9	05-04-2023	03-31-2023	10-Q
10	02-16-2023	12-31-2022	10-K
11	11-01-2022	09-30-2022	10-Q
12	08-02-2022	06-30-2022	10-Q
13	05-03-2022	03-31-2022	10-Q
14	02-17-2022	12-31-2021	10-K
15	10-28-2021	09-30-2021	10-Q
16	07-29-2021	06-30-2021	10-Q
17	04-29-2021	03-31-2021	10-Q
18	02-17-2021	12-31-2020	10-K
19	10-29-2020	09-30-2020	10-Q
20	07-31-2020	06-30-2020	10-Q
21	05-06-2020	03-31-2020	10-Q
22	02-13-2020	12-31-2019	10-K
23	11-05-2019	09-30-2019	10-Q
24	08-01-2019	06-30-2019	10-Q
25	05-09-2019	03-31-2019	10-Q
26	02-26-2019	12-31-2018	10-K
27	10-30-2018	09-30-2018	10-Q
28	08-01-2018	06-30-2018	10-Q
29	05-02-2018	03-31-2018	10-Q
30	02-21-2018	12-31-2017	10-K
31	10-31-2017	09-30-2017	10-Q
32	08-02-2017	06-30-2017	10-Q
33	05-03-2017	03-31-2017	10-Q
34	03-09-2017	12-31-2016	10-K
35	11-10-2016	09-30-2016	10-Q
36	08-09-2016	06-30-2016	10-Q
37	05-10-2016	03-31-2016	10-Q
38	03-11-2016	12-31-2015	10-K
39	11-09-2015	09-30-2015	10-Q
40	08-10-2015	06-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

sanofi-expands-respiratory-vaccine-portfolio-with-uk-biotech-buy

Sanofi Expands Respiratory Vaccine Portfol...
07/22/2025 18:09:38

Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its ...

Trading Halt: Halt status updated at 8:45:...
07/17/2025 12:45:04

What's Driving the Market Sentiment Around...
07/14/2025 19:01:04

cogents-chronic-immune-disorder-drug-has-strong-potential-to-become-a-blockbuster-analyst

Cogent's Chronic Immune Disorder Drug Has ...
07/08/2025 18:26:44

Cogent's bezuclastinib showed strong efficacy in a non-advanced SM trial, with a planned FDA submission expected by the end...

Wells Fargo Downgrades Blueprint Medicines...
06/18/2025 12:50:52

Wells Fargo analyst Derek Archila downgrades Blueprint Medicines (NASDAQ:BPMC) from Overweight to Equal-Weight and lowers th...

nvidia-to-rally-more-than-38-here-are-10-top-analyst-forecasts-for-tuesday

Nvidia To Rally More Than 38%? Here Are 10...
06/17/2025 14:00:22

Wells Fargo Downgrades Blueprint Medicines...
06/17/2025 13:42:16

Wells Fargo analyst Derek Archila downgrades Blueprint Medicines (NASDAQ:BPMC) from Overweight to Equal-Weight and lowers th...

Blueprint Medicines Reveals Data Reinforci...
06/12/2025 22:04:53

applied-digital-and-riot-platforms-are-among-top-10-mid-cap-gainers-last-week-jun-2-jun-6-are-the-others-in-your-portfolio

Applied Digital And Riot Platforms Are Amo...
06/08/2025 15:45:33

deal-dispatch-tv-stations-for-sale-this-buyer-wants-seconds-on-pasta

Deal Dispatch: TV Stations For Sale, This ...
06/06/2025 19:37:15

Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week plus bankruptcy updates.

Morgan Stanley Maintains Equal-Weight on B...
06/05/2025 17:39:50

Morgan Stanley analyst Judah Frommer maintains Blueprint Medicines (NASDAQ:BPMC) with a Equal-Weight and raises the price ta...

UBS Maintains Neutral on Blueprint Medicin...
06/05/2025 12:51:21

UBS analyst David Dai maintains Blueprint Medicines (NASDAQ:BPMC) with a Neutral and raises the price target from $88 to $129.

this-snowflake-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday

This Snowflake Analyst Turns Bullish; Here...
06/04/2025 13:37:15

Citigroup Upgrades Blueprint Medicines to ...
06/04/2025 12:35:04

Citigroup analyst David Lebowitz upgrades Blueprint Medicines (NASDAQ:BPMC) from Sell to Neutral and raises the price target...

JMP Securities Downgrades Blueprint Medici...
06/03/2025 14:12:59

JMP Securities analyst Reni Benjamin downgrades Blueprint Medicines (NASDAQ:BPMC) from Market Outperform to Market Perform.

this-asml-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

This ASML Analyst Is No Longer Bullish; He...
06/03/2025 13:20:29

this-salesforce-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday

This Salesforce Analyst Begins Coverage On...
06/03/2025 13:11:50

Stephens & Co. Downgrades Blueprint Medici...
06/03/2025 11:11:18

Stephens & Co. analyst Sudan Loganathan downgrades Blueprint Medicines (NASDAQ:BPMC) from Overweight to Equal-Weight and...

Wolfe Research Downgrades Blueprint Medici...
06/03/2025 11:05:30

Wolfe Research analyst Andy Chen downgrades Blueprint Medicines (NASDAQ:BPMC) from Outperform to Peer Perform.

Scotiabank Downgrades Blueprint Medicines ...
06/02/2025 17:28:01

Scotiabank analyst Louise Chen downgrades Blueprint Medicines (NASDAQ:BPMC) from Sector Outperform to Sector Perform and ann...